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تقييم استخدام املضادات احليوية عند املصابني باإلنتان يف وحدة عناية مركزة
دراسة مستعرضة يف مستشفى مرجعي بإندونيسيا
راتنا �شاري دووي، ماك�شوم رادجي، رزقا اأندلو�شيا
abstract: Objectives: This study aimed to evaluate the appropriateness of antibiotic use and factors associated with 
outcomes among sepsis patients in an intensive care unit (ICU). Methods: This cross-sectional study was carried out 
from February to May 2017 and included all adult patients with sepsis or septic shock admitted to the ICU of Dharmais 
Cancer Hospital, Jakarta, Indonesia. Data were collected from the patients’ medical records. Results: A total of 60 
patients with sepsis or septic shock were admitted to the ICU during the study period. The most common source 
of infection was hospital-acquired pneumonia (61.7%) and the majority had two or more comorbidities (93.3%). 
There were 115 antibiotic regimens prescribed. Overall, 33.3% of patients were prescribed inappropriate types of 
antibiotics and 51.7% were given an inappropriate dosage. The mortality rate was 68.3%. There was a statistically 
significant association between patient outcome and inappropriate doses of antibiotics (P = 0.034), although not 
inappropriate types of antibiotics (P = 0.050). A multivariate analysis indicated that the main factors influencing 
patient outcome were septic shock and the presence of at least two comorbidities (P <0.050 each). Conclusion: Inappr- 
opriate doses of antibiotics, a diagnosis of septic shock and the presence of at least two comorbidities were found to 
significantly increase the mortality rate of sepsis patients admitted to an ICU in Indonesia.
Keywords: Drug Prescription, trends; Antibiotics; Sepsis; Septic Shock; Intensive Care Units; Indonesia.
امللخ�ص: الهدف: هدفت هذه الدرا�شة لتقومي مالئمة ا�شتخدام امل�شادات احليوية، والعوامل املرتبطة بنتائج ذلك عند امل�شابني بالإنتان 
املر�شى  من  البالغني  كل  و�شملت   ،2017 عام  اأبريل  اإىل  فرباير  من  امل�شتعر�شة  الدرا�شة  هذه  اأجريت  الطريقة:  مركزة.  عناية  وحدة  يف 
امل�شابني بالإنتان اأو ال�شدمة النتانية الذين اأدخلوا يف وحدة العناية املركزة يف م�شت�شفى دهارميا�ص لعالج لل�رسطان بجاكارتا يف 
اإندوني�شيا. وجمع املعلومات من �شجالت املر�شى. النتائج: اأُدخل �شتون مري�شا بالإنتان اأو ال�شدمة النتانية للعناية املركزة خالل فرتة 
الدرا�شة. وكان اأكرب �شبب العدوى هو التهاب الرئة املكت�شب يف امل�شت�شفى )%61.7(، كان غالبهم م�شابا اأي�شا مبر�شني م�شاحبني اأو اأكرث 
)%93.3(. ومت و�شف 115 من نظم امل�شادات احليوية. ووجد على وجه العموم اأن %33.3 من امل�شادات املو�شوفة للمر�شى كانت غري 
مالئمة، واأن %51.7 من املر�شى كانوا قد اأُعطيوا امل�شادات بجرعات غري مالئمة. وبلغت ن�شبة الوفيات بني اأولئك املر�شى %68.3. ووجد 
اأن هنالك عالقة اإح�شائية معتدة بني ما حدث من نتائج عند املر�شى وعدم مالئمة جرعات امل�شادات احليوية )P = 0.034(، ولكن لي�ص 
بينها وبني مالئمة امل�شادات نف�شها )P = 0.050(. واأو�شح حتليل متعدد املتغريات اأن ال�شبب الرئي�ص ملا حدث للمر�شى كان هو ال�شدمة 
اأن عدم مالئمة جرعات امل�شادات احليوية،  اخلال�صة: وجد  )P >0.050 يف كل حالة(.  النتانية، ووجود مر�شني م�شاحبني على الأقل 
وت�شخي�ص حدوث �شدمة اإنتانية، مع وجود مر�شني م�شاحبني اأو اأكرث هي ما يزيد ب�شورة يعتد بها من الوفيات عند املر�شى امل�شابني 
بالإنتان يف ق�شم للعناية املركزة مب�شت�شفى يف اندوني�شيا.
الكلمات املفتاحية: و�شفات الأدوية، اجتاهات؛ م�شادات حيوية؛ اإنتان؛ �شدمة اإنتانية؛ وحدة عناية مركزة؛ اإندوني�شيا.
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Advances in Knowledge
- This study found that the mortality rate of sepsis patients admitted to an intensive care unit in Indonesia was quite high.
- Factors found to significantly influence mortality included inappropriate doses of antibiotics, a diagnosis of septic shock and the presence of at least 
two comorbidities.
Application to Patient Care
- The results of this study could be used by physicians, pharmacists and other healthcare workers to increase the appropriate use of antibiotics, 
perhaps by implementing an antibiotic stewardship programme or with the formulation of guidelines for appropriate antibiotic usage based on the 
source of infection and the patient’s clinical condition. 
Sepsis is a life-threatening condition caused by a dysregulated host response to infection leading to organ dysfunction.1 It is most likely to develop 
in individuals with a weakened immune system, often 
because of treatments such as chemotherapy. However, 
critically-ill patients are also at risk due to the prev-
alence of drug-resistant bacteria in hospital settings and 
the need for catheterisation and wound drainage.2 Sepsis 
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occurs in approximately 2% of all hospitalised cases and 
among 6–30% of all patients admitted to intensive care 
units (ICUs) in developed countries.3,4 Both sepsis and 
septic shock are leading causes of morbidity and mort-
ality in ICUs (21% and 28%, respectively).4–6
The management of sepsis or septic shock requires a 
comprehensive and systematic approach combining the 
use of appropriate diagnostic measures, the rapid initi-
ation of appropriate empirical antibiotics and the admin-
istration of supportive therapy.7 According to internat- 
ional guidelines for the management of sepsis and septic 
shock, appropriate antimicrobials should be administered 
within one hour of diagnosis, with the dosage optimised 
according to standard pharmacokinetic/pharmacodyn-
amic principles.8 In addition, the patient’s location at the 
time of infection, the source of the infection and the 
prevalence and susceptibility patterns of common local 
pathogens should also be factored into the choice of 
therapy.8,9 
In ICUs, antibiotics are the most common type of 
medicine and are prescribed approximately 10 times more 
than in general hospital wards.10 However, inappropriate 
therapy and delays in prescribing appropriate antibiotics 
are important factors related to increased morbidity and 
mortality in sepsis patients.8,11,12 In Thailand, there were 
229 cases of sepsis reported in 2012, of which 61.6% 
developed septic shock; the overall mortality rate for 
patients who were prescribed first-dose inappropriate 
and appropriate antibiotics was 75% and 68.3%, resp-
ectively.13 In a referral hospital in Indonesia, there were 
126 cases of sepsis admitted between 2011 and 2012; 
the mortality rate was 81.8% and 66.7%, respectively, for 
patients prescribed inappropriate types and doses of 
antibiotics.14
The Dharmais Cancer Hospital is a 364-bed tertiary 
care hospital in Jakarta, Indonesia, which also serves as 
a cancer referral centre. According to a retrospective study, 
18.5% of patients admitted to this hospital between 2011 
and 2012 had sepsis.9 However, to the best of the authors’ 
knowledge, no studies have yet evaluated the appropr-
iateness of antibiotic usage for sepsis patients in the 
hospital’s ICU. This study therefore aimed to evaluate 
the appropriateness of antibiotic use with regards to 
antibiotic type and dosage and factors associated with 
patient outcomes among ICU patients with sepsis or 
septic shock admitted to Dharmais Cancer Hospital.
Methods
This cross-sectional study was carried out between 
February and May 2017 in the ICU of Dharmais Cancer 
Hospital. All adult sepsis or septic shock patients who 
were receiving antibiotic therapy and were hospitalised 
in the ICU for at least 24 hours during the study period 
were included. Patients with incomplete medical records, 
those who had subsequent episodes of sepsis/septic 
shock or who were admitted for less than 24 hours and 
those who were under 18 years of age were excluded. In 
addition, patients readmitted to the ICU during the 
study period were not evaluated again. The required 






where is 1.96 (at a 95% confidence interval), P is
10% (the expected proportion of sepsis) and d is 0.1 
(the relative precision).15,16 Therefore, the total sample 
size required was 35 patients.
1-Z α2
Table 1: Recommended antibiotic regimen in sepsis cases 





CAP • β-lactam (i.e. ceftriaxone, cefotaxime or 
ampicillin/sulbactam) plus azithromycin
• β-lactam (i.e. ceftriaxone, cefotaxime 
or ampicillin/sulbactam) plus respiratory 




• Antipseudomonal β-lactam (i.e. piperacillin/
tazobactam, cefepime, meropenem, imipenem 
or doripenem) plus aminoglycosides (i.e. 
gentamicin, tobramycin or amikacin) or 
antipseudomonal flouroquinolone (i.e. 
levofloxacin or ciprofloxacin)* 
Blood stream
CRBSI • Vancomycin or daptomycin† plus 
antipseudomonal β-lactam (i.e piperacillin/
tazobactam and cefepime) or carbapenem (i.e. 
meropenem, imipenem or doripenem) with 
or without an aminoglycoside (i.e. gentamicin, 
tobramycin or amikacin)
Urinary
Urosepsis • Third-generation cephalosporin (ceftriaxone 
or cefotaxime) with or without an 
aminoglycoside (gentamicin, tobramycin or 




• Antipseudomonal β-lactam (i.e piperacillin/
tazobactam and cefepime) or carbapenem (i.e. 
meropenem, imipenem or doripenem)‡
Unknown
Unspecified • Antipseudomonal β-lactam (i.e piperacillin/
tazobactam and cefepime) or carbapenem 
(i.e. meropenem, imipenem or doripenem) 
plus an aminoglycoside or antipseudomonal 
flouroquinolon (i.e. levofloxacin or 
ciprofloxacin) plus vancomycin
CAP = community-acquired pneumonia; HAP = hospital-acquired pneu-
monia; HCAP = healthcare-associated pneumonia; VAP = ventilator-assoc-
iated pneumonia; CRBSI = catheter-related blood-stream infection.
*Vancomycin or linezolid can be added if methicillin-resistant Staphylococcus 
aureus is suspected.  †If there is a high rate of resistance to vancomycin 
(minimum inhibitory concentration of ≥2 µg/mL).  ‡This regimen is also 
recommended if there is a risk of multidrug resistance.
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The diagnosis of sepsis and septic shock were based 
on international criteria.1 Data were collected from the 
patients’ medical and drug-prescribing records using a 
predesigned structured form. This included the patients’ 
demographic characteristics, diagnosis, length of stay 
(LOS), Sequential Organ Failure Assessment (SOFA) 
score, the presence of co-morbidities (i.e. malignancy, 
diabetes mellitus, cardiovascular disease, chronic kidney 
disease, liver disease or respiratory insufficiency), source 
of infection, ventilator use, causative pathogens, antibi- 
otic usage (i.e. type and dose), the timing of the specimen 
collection for culture and outcome. In addition, samples 
of blood, sputum, bronchial rinse and urine were collected 
for cultures and antimicrobial sensitivity testing. 
Antibiotics were assessed for appropriateness acc- 
ording to type and dosage. Local microbial patterns during 
the period of June to December 2016 in the ICU 
were used to determine antimicrobial susceptibility 
data.9 The type of antibiotic prescribed during 
the study period was subsequently deemed appr- 
opriate if it was prescribed empirically according to the 
local microbial susceptibility data, whereas it was deemed 
to be inappropriate if it did not reflect the susceptibility 
data. This assessment was undertaken by the Antibiotic 
Stewardship Committee of the hospital, consisting of 
physicians, clinical pharmacists and nurses. Additionally, 
the appropriateness of each type of antibiotic was cons-
idered in light of the source of infection, as determined 
by the attending physician [Table 1].17–20 The initial dose 
of the antibiotic was deemed appropriate after adjustment 
for the patient’s clinical condition, while unadjusted dos- 
ages were considered inappropriate.21 
Data were analysed using the Statistical Package 
for the Social Sciences (SPSS), Version 23.0 (IBM Corp., 
Armonk, New York, USA). The independent variable 
was the appropriateness of the antibiotics (according to 
dose and type) and the dependent variable was patient 
outcome. Other variables included age, gender, diagnosis, 
number of comorbidities, ventilator use and SOFA score. 
Differences in the appropriateness of antibiotics based 
on local microbial patterns were presented as descriptive 
data, while differences in the appropriateness of anti-
biotics based on the source of infection and dosage were 
presented as both descriptive and analytical data. A corr- 
ected Chi-squared test was used to determine if the diff-
erences were significant. All correlations with a P value 
of <0.250 were included in a subsequent multivariate 
analysis. A logistic regression analysis was performed to 
identify factors influencing patient outcome. A P value 
of <0.050 was considered statistically significant.
Ethical approval for this study was obtained from 
the Ethical Committee of Dharmais Cancer Hospital 
(#013/KEPK/II/2017). No patient consent was deemed 
necessary as permission to review the medical records 
was granted by the appropriate authorities at Dharmais 
Table 2: Characteristics of sepsis patients admitted to the intensive 












Septic shock 29 (48.3)
Length of stay in days
≥7 12 (20)
<7 48 (80)



















Respiratory insufficiency 51 (85)
Cardiovascular disease 20 (33.3)
Chronic kidney disease 16 (26.7)
Liver disease 7 (11.7)
Diabetes mellitus 2 (3.3)
SD = standard deviation; SOFA = Sequential Organ Failure Assessment; 
HAP = hospital-acquired pneumonia; IAI = intra-abdominal infection; CAP 
= community-acquired pneumonia; UTI = urinary tract infection; HCAP = 
healthcare-associated pneumonia. *Percentages do not add up to 100% as 
some patients may have had more than one comorbidity.
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Cancer Hospital. All information obtained during the 
review of the records was kept confidential and used 
only for the purposes of this study. 
Results
A total of 182 patients were admitted to the ICU of 
Dharmais Cancer Hospital during the study period. Of 
these, 60 adults (33%) were diagnosed with either sepsis 
(51.7%) or septic shock (48.3%). The mean age of the 
patients was 51.4 ± 11.7 years (range: 24–82 years old) 
and 53.3% were male. The median LOS was 4.0 ± 4.4 
days (range: 2–23 days), with 80% staying less than seven 
days. Most patients had a SOFA score of ≤8 (51.7%) and 
used a ventilator (86.7%). The most common source of 
infection was hospital-acquired pneumonia (HAP; 61.7%), 
followed by intra-abdominal infections (IAI; 18.3%). 
Almost all of the patients had two or more comorb-
idities (93.3%), with the most frequent being malignancy 
(100%) and respiratory insufficiency (85%) [Table 2].
Blood, sputum, bronchial rinse and urine samples 
were available for 49 patients (81.7%). A total of 66 cult-
ures were taken from the samples, of which 44 (66.7%) 
were positive and 22 (33.3%) were negative. Overall, 
21 microorganisms were detected in the positive cult- 
ures, the most common being Acinetobacter baumannii 
(15.2%), followed by Escherichia coli (6.1%), Klebsiella 
pneumoniae (4.6%) and Staphylococcus haemolyticus 
(4.6%). Of the isolates from positive cultures, 41 (93.2%) 
were known to be susceptible to antibiotics, while the 
remaining three (6.8%) contained only fungi. In total, 
39.3% of the microorganisms were resistant to the anti- 
biotic administered, 28.6% were sensitive to the antibiotic 
administered, 4.8% had intermediate resistance to the 
antibiotic administered or required a higher dose and 
27.4% were not tested for sensitivity. Pseudomonas 
aeruginosa was the most sensitive to the administered 
antibiotics (87.5%), while A. baumannii was the most 
resistant (72.2%).
In total, there were 115 different antibiotic regimens, 
of which eight (7%) constituted definitive therapy and 
107 (93%) were empirical. A total of 16 antibiotics were 
prescribed. Meropenem (41.1%) was most frequently 
prescribed, followed by levofloxacin (20%) and amikacin 
(11.3%). Levofloxacin was prescribed in three of the def- 
initive regimens (37.5%) [Figure 1]. The most common 
antibiotic regimens consisted of meropenem (16% in 
HAP cases, 40% in community-acquired pneumonia 
(CAP) cases, 50% in IAI cases and 33.3% in cases 
wherein the source of infection was unknown), mero- 
penem plus levofloxacin (26% in HAP cases, 40% in 
Table 3: Correlations between appropriateness of type and 
dose of antibiotics and outcome among sepsis patients 
admitted to the intensive care unit of Dharmais Cancer 
Hospital, Jakarta, Indonesia (N = 60)







Inappropriate 20 (33.3) 17 (85) 3 (15) 0.050
Appropriate 40 (66.7) 24 (60) 16 (40)
Dose of antibiotic
Inappropriate 31 (51.7) 25 (80.6) 6 (19.4) 0.034
Appropriate 29 (48.3) 16 (55.2) 13 (44.4)
*Using a Chi-squared test.
 
Figure 1: Distribution of empirical and definitive antibiotic regimens prescribed to sepsis patients admitted to the 
intensive care unit of Dharmais Cancer Hospital, Jakarta, Indonesia.
*Inappropriate according to local microbial patterns/antimicrobial susceptibility data.
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CAP cases and 14.3% in IAI cases), cefepime plus amik-
acin (100% in healthcare-associated pneumonia cases), 
cefotaxime and ceftriaxone plus levofloxacin (50% each 
in urinary tract infection cases). Overall, 23 patients 
(38.3%) received one antibiotic, 26 (43.3%) received 
two antibiotics, four (6.7%) received three antibiotics, 
five (8.3%) received four antibiotics and two (3.3%) 
received five antibiotics.
A total of 20 patients (33.3%) received inappropriate 
types of antibiotics according to either local microbial 
patterns or the source of infection (45.2% and 25%, 
respectively). Inappropriate doses of antibiotics were 
prescribed to 31 patients (51.7%), with dose adjustments 
required by 16 patients (26.7%). The mortality rate was 
68.3%. There was a statistically significant positive assoc- 
iation between patient outcome and inappropriate doses 
of antibiotics (P = 0.034), but not inappropriate types of 
antibiotics (P = 0.050) [Table 3]. According to a bivariate 
analysis, a diagnosis of septic shock, having at least two 
comorbidities, ventilator use, a SOFA score of >8 and 
the presence of a liver disorder had an effect on 
mortality (P <0.250 each) [Table 4]. A multivariate 
analysis indicated that a diagnosis of septic shock 
and the presence of at least two comorbidities were 
significantly associated with mortality (P <0.050 each) 
[Table 5].
Discussion
In the current study, sepsis was more common 
among patients under 60 years old, although the 
mortality rate was higher among those over 60 years 
old. In the USA, the risk of sepsis increases with every 
Table 4: Correlations between risk factors and outcome 
among sepsis patients admitted to the intensive care unit 
of Dharmais Cancer Hospital, Jakarta, Indonesia (N = 60)







≥60 12 (20) 9 (75) 3 (25)
0.579
<60 48 (80) 32 (66.7) 16 (33.3)
Gender
Male 32 (53.3) 23 (71.9) 9 (28.1)
0.528
Female 28 (46.7) 18 (64.3) 10 (35.7)
Diagnosis
Sepsis 31 (51.7) 15 (48.4) 16 (51.6)
0.001
Septic shock 29 (48.3) 26 (89.7) 3 (10.3)
Ventilator use
Yes 52 (86.7) 37 (71.2) 15 (28.8)
0.231
No 8 (13.3) 4 (50) 4 (50)
SOFA score
>8 29 (48.3) 25 (86.2) 4 (13.8)
0.004
≤8 31 (51.7) 16 (51.6) 15 (48.4)
Number of comorbidities
≥2 56 (93.3) 40 (71.4) 16 (28.6)
0.054
<2 4 (6.7) 1 (25) 3 (75)
Type of comorbidity
Malignancy 60 (100) 41 (68.3) 19 (31.7) -
Respiratory 
insufficiency
51 (85) 36 (70.6) 15 (29.4) 0.371
Cardiovascular 
disease
20 (33.3) 15 (75) 5 (25) 0.432
Chronic 
kidney disease
16 (26.7) 12 (75) 4 (25) 0.503
Liver disease 7 (11.7) 7 (100) 0 (0) 0.055
Diabetes 
mellitus
2 (3.3) 2 (100) 0 (0) 0.327
SOFA = Sequential Organ Failure Assessment.
*Using a Chi-squared test.
Table 5: Multivariate analysis showing correlations bet- 
ween risk factors and outcome of sepsis patients in the 
intensive care unit of Dharmais Cancer Hospital, Jakarta, 
Indonesia (N = 60)
Factors OR (95% CI) P value*
Step 1 Septic shock 0.064 (0.007–0.573) 0.014
Presence of liver 
disease
0.000 0.999




≥2 comorbidities 0.042 (0.002–1.018) 0.051
Constant 78.297 0.015
Step 2 Septic shock 0.063 (0.007–0.561) 0.013






≥2 comorbidities 0.033 (0.001–0.786) 0.035
Constant 51.619 0.018




≥2 comorbidities 0.023 (0.001–0.556) 0.020
Constant 71.819 0.012
OR = odds ratio; CI = confidence interval; SOFA = Sequential Organ 
Failure Assessment.
*Using a logistic regression test. 
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year of age by 1.5%.22 Increased age over 60 years 
is a predictor of mortality in sepsis, particularly if 
adequate empirical antibiotic therapy is not initiated.23 
In terms of gender, there were slightly more male 
than female patients in the current study. However, 
the frequency of sepsis among male patients was 
higher in a similar study conducted by Ferrer et al. 
(61.9%).24 Adrie et al. demonstrated that older men are 
more vulnerable to sepsis than women.25 Another study 
showed that cross-linked mutations or polymorphisms 
in female mice resulted in the more dynamic activation, 
regulation and function of immune cells during the 
inflammatory process, while male mice only demonstr-
ated a partial response to inflammation.26
Unfortunately, the mortality rate of patients with 
septic shock in ICUs remains high, despite fluid resusc- 
itation measures, adequate care and the early administr-
ation of empirical antibiotics.27 In the current study, a 
diagnosis of septic shock was significantly associated 
with mortality, despite septic shock being less common. 
In a similar study, Ogura et al. reported that 45.2% of 
Japanese patients were diagnosed with septic shock, with 
a significantly higher mortality rate in this group (63.6% 
versus 37.5%; P <0.010).28 In sepsis, venodilation, fluid 
transudation from the vesicular space into the tissues, 
decreased oral intake and increased fluid loss facilitates 
the occurrence of hypovolaemic events; in septic shock, 
ventricular dysfunction and arteriolar dilatation contr- 
ibute to the failure of function and organ perfusion.27 
HAP is one of the most frequent and severe complic-
ations observed among patients hospitalised in ICUs.29 
In the current study, HAP was the most frequent source 
of infection. However, Katu et al. found CAP to be 
most common among sepsis patients in a referral 
hospital in Indonesia.14 This could be due to differences 
in the location of the study, the sample and incidence 
of infections, as well as the extent of each individual 
patient’s immune response.
Empirical antibiotic therapy is key in the initial 
management of sepsis patients. The type of antibiotic to be 
prescribed is usually determined by an assessment of the 
potential pathogens responsible for the infection, taking 
into account local antibiotic susceptibility patterns.30 
However, failure to determine the source of infection can 
potentially lead to the misidentification of pathogens, 
resulting in the inappropriate selection of antibiotics.8,9 
Previous research has established that the administr-
ation of inappropriate antimicrobials substantially incr- 
eases mortality among sepsis patients.8,11–13 In the current 
study, a significant association was noted between inappr- 
opriate doses of antibiotics and mortality; however, there 
was no significant association between inappropriate 
types of antibiotics and mortality. In contrast, Katu et al. 
found that inappropriate types of antibiotics were sign-
ificantly associated with mortality.14 This variation in 
results may again be due to differences in the sample as 
well as study design, such as the inclusion and exclusion 
criteria and antibiotic guidelines used. Nevertheless, 
the multivariate analysis in the present study indicated 
that the most significant factors associated with mort- 
ality were septic shock and the presence of at least two 
comorbidities; therefore, regardless of the appropriat-
eness of the antibiotics administered, the mortality rate 
was still high. This is likely due to the critical clinical cond- 
ition of such patients, which is generally poor in light 
of their admission to the ICU.
According to international guidelines, it is strongly 
recommended that appropriate antimicrobial therapy 
be administered within one hour of recognising cases 
of sepsis or septic shock.8 However, the exact antibiotic 
delivery time in the current study could not be assessed 
as almost all of the patients had received antibiotics 
prior to their admission to the ICU. Furthermore, anti-
microbial sensitivity testing was not performed for all 
of the antibiotics administered during the study period 
due to interdepartmental miscommunication, wherein 
staff of the microbiology laboratory were unaware of 
the specific antibiotics being administered to sepsis 
patients in the ICU. Additionally, as the Antibiotic Stew- 
ardship Committee was still under development during 
this time, no uniform reference was available for the 
selection of antibiotics by hospital staff. Finally, microbial 
cultures could not be performed in 11 cases due to diff- 
iculties collecting samples from these patients.
Conclusion
This study found that inappropriate doses of antibiotics 
were significantly associated with mortality among sepsis 
patients in an Indonesian ICU, although inappropriate 
types of antibiotics were not. Furthermore, a diagnosis 
of septic shock and the presence of at least two comorb- 
idities were significant risk factors related to mortality.
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